Bespoke Extracts (BSPK) 10-Q 9 Jul 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	May 31, 2020	Jul. 08, 2020
Document and Entity Information [Abstract]
Entity Registrant Name	Bespoke Extracts, Inc.
Entity Central Index Key	0001409197
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Document Type	10-Q
Document Period End Date	May 31, 2020
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		153,389,621
Entity File Number	000-52759
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	NV

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	May 31, 2020	Aug. 31, 2019
Current assets
Cash	$ 301	$ 10,343
Accounts receivable, net	3,636	6,452
Prepaid expense	11,500	17,637
Inventory, net	1,264	3,171
Total current assets	16,701	37,603
Domain names, net of amortization of $10,061 and $8,364, respectively	33,742	41,821
Total assets	50,443	79,424
Current liabilities
Accounts payable and accrued liabilities	41,181	111,056
Convertible notes - net of unamortized discounts $0 and $0, respectively	500,000
Total current liabilities	541,181	111,056
Commitments and contingencies (Note 6)
Stockholders' Deficit
Preferred stock, value
Common stock, $0.001 par value: 800,000,000 shares authorized; 130,388,426 and 78,155,093 shares issued and outstanding as of May 31, 2020 and August 31, 2019, respectively	130,389	78,156
Additional paid-in capital	17,992,634	13,950,095
Common stock payable	76,000	76,000
Accumulated deficit	(18,689,762)	(14,135,883)
Total stockholders' deficit	(490,738)	(31,632)
Total liabilities and stockholders' deficit	50,443	79,424
Series A Convertible Preferred Stock
Stockholders' Deficit
Preferred stock, value
Series B Preferred Stock
Stockholders' Deficit
Preferred stock, value
Series C Preferred Stock
Stockholders' Deficit
Preferred stock, value	$ 1

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - USD ($)	May 31, 2020	Aug. 31, 2019
Net of amortization cost	$ 10,061	$ 8,364
Convertible debt, unamortized discounts	$ 0	$ 0
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	1	0
Preferred stock, shares outstanding	1	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	800,000,000	800,000,000
Common stock, shares issued	130,388,426	78,155,093
Common stock, shares outstanding	130,388,426	78,155,093
Series A Convertible Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Preferred stock, designated shares	1,000	1,000
Series B Preferred Stock
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred stock, designated shares	1	1
Preferred stock stated value	$ 24,000
Series C Preferred Stock
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares issued	1
Preferred stock, shares outstanding	1
Preferred stock, designated shares	1	1
Preferred stock stated value	$ 24,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2020	May 31, 2019	May 31, 2020	May 31, 2019
Income Statement [Abstract]
Sales		$ 1,874	$ 1,739	$ 55,814
Cost of products sold		1,378	1,087	17,266
Gross Profit		496	652	38,548
Operating expenses:
Selling, general and administrative expenses	3,161,806	153,568	3,594,236	(3,685,213)
Professional fees	25,367	35,308	174,153	141,791
Consulting	24,562	132,100	158,062	246,600
Amortization expense and impairment of domain name	811	836	2,797	2,509
Total operating expenses	3,212,546	321,812	3,929,248	(3,294,313)
Income / (Loss) from operations	(3,212,546)	(321,316)	(3,928,596)	3,332,861
Other expense
Financing common share expense				(76,000)
Loss on settlement of debt			(89,595)
Interest expense and amortization of debt discount	(242,188)	(124,560)	(535,688)	(357,472)
Total other expense	(242,188)	(124,560)	(625,283)	(433,472)
Income / (Loss) before income tax	(3,454,734)	(445,876)	(4,553,879)	2,899,389
Provision for income tax
Net Income / (Loss)	$ (3,454,734)	$ (445,876)	$ (4,553,879)	$ 2,899,389
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic and Diluted	111,910,165	66,826,522	105,433,560	54,709,881
NET INCOME / (LOSS) PER COMMON SHARE OUTSTANDING
Basic and Diluted	$ (0.03)	$ (0.01)	$ (0.04)	$ 0.05

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	May 31, 2020	May 31, 2019
Cash flows from operating activities
Net Income / (Loss)	$ (4,553,879)	$ 2,899,389
Adjustments to reconcile net income (loss) to net cash used in operating activities
Amortization and impairment expense of domain names	2,797	2,509
Amortization of debt discounts	535,687	298,147
Bad debt expense	2,981	3,304
Loss on settlement of debt	89,595
Gain on forfeited unvested employee stock award (net of cash paid of $1,600)		(2,440,768)
Option and warrant expense	3,467,440	(1,540,710)
Common stock issued for services	40,500	181,950
Financing common share expense		76,000
Changes in operating assets and liabilities:
Accounts receivable	(165)	(3,947)
Inventory	1,907	9,037
Prepaid expense	6,137	16,589
Accounts payable and accrued liabilities	(542)	125,703
Net Cash used in operating activities	(407,542)	(372,797)
Cash flow from financing activities
Proceeds from the issuance of convertible debt	400,000
Proceeds from exercise of warrants and options for cash	20,000	2,000
Repayment of debt	(120,000)
Repurchase of common stock	(27,500)
Sale of common stock	125,000	405,500
Net cash provided by financing activities	397,500	407,500
Net increase / (decrease) in cash and cash equivalents	(10,042)	34,703
Cash and cash equivalents at beginning of period	10,343	79,784
Cash and cash equivalents at end of period	301	114,487
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities:
Discount beneficial conversion feature	281,300
Stock issued with convertible debt	118,700	978,340
Preferred stock issued for the conversion of accrued salary	24,000
Capital contribution of accrued salary - related party	45,333
Assignment of URL for settlement of debt	$ 5,282

Condensed Statements of Cash _2

Condensed Statements of Cash Flows (Parenthetical)	9 Months Ended
	May 31, 2020USD ($)
Statement of Cash Flows [Abstract]
Gain on forfeited unvested employee stock award	$ 1,600

Condensed Statement of Stockhol

Condensed Statement of Stockholders Equity / (Deficit) (Unaudited) - USD ($)	Series A Preferred Shares	Series B Preferred Shares	Series C Preferred Shares	Common Shares Outstanding	APIC	Common Stock Payable	Accumulated Deficit	Total
Balance at Aug. 31, 2018				$ 42,903	$ 16,246,201		$ (16,716,644)	$ (427,540)
Balance, shares at Aug. 31, 2018				42,902,712
Preferred stock issued for the conversion of accrued salary
Sale of common stock				$ 14,553	390,947			405,500
Sale of common stock, shares				14,552,381
Forfeiture of stock issued through warrant exercise, net of cash paid				$ (16,000)	(2,424,768)			(2,440,768)
Forfeiture of stock issued through warrant exercise, net of cash paid, shares				(16,000,000)
Common stock issued for the exercise of warrants				$ 20,000	(18,000)			2,000
Common stock issued for the exercise of warrants, shares				20,000,000
Common stock issued for services				$ 20,000	179,950			181,950
Common stock issued for services, shares				20,000,000
Option and warrant expense					(1,540,710)			(1,540,710)
Financing common share expense						76,000		76,000
Conversion of debt to common stock				$ 14,000	964,340			978,340
Conversion of debt to common stock, shares				14,000,000
Net income loss							2,899,389	2,899,389
Balance at May. 31, 2019				$ 77,456	13,797,960	76,000	(13,817,255)	134,161
Balance, shares at May. 31, 2019				77,455,093
Balance at Feb. 28, 2019				$ 56,870	12,568,886	76,000	(13,371,379)	(669,623)
Balance, shares at Feb. 28, 2019				56,869,379
Sale of common stock				$ 5,586	114,914			120,500
Sale of common stock, shares				5,585,714
Common stock issued for services				$ 1,000	60,950			61,950
Common stock issued for services, shares				1,000,000
Option and warrant expense					88,870			88,870
Conversion of debt to common stock				$ 14,000	964,340			978,340
Conversion of debt to common stock, shares				14,000,000
Net income loss							(445,876)	(445,876)
Balance at May. 31, 2019				$ 77,456	13,797,960	76,000	(13,817,255)	134,161
Balance, shares at May. 31, 2019				77,455,093
Balance at Aug. 31, 2019				$ 78,156	13,950,095	76,000	(14,135,883)	(31,632)
Balance, shares at Aug. 31, 2019				78,155,093
Preferred stock issued for the conversion of accrued salary		$ 1			23,999			24,000
Preferred stock issued for the conversion of accrued salary, shares		1
Sale of common stock				$ 20,833	104,167			125,000
Sale of common stock, shares				20,833,333
Common stock issued for services				$ 4,500	36,000			40,500
Common stock issued for services, shares				4,500,000
Option and warrant expense					3,467,440			3,467,440
Exercise of stock options				$ 20,000				20,000
Exercise of stock options, shares				20,000,000
Exchange of preferred stock		$ (1)	$ 1
Exchange of preferred stock, shares		(1)	1
Capital contribution of accrued salary - related party					45,333			45,333
Financing common share expense
Common stock issued with debt				$ 9,900	108,800			118,700
Common stock issued with debt, shares				9,900,000
Repurchase of common stock				$ (3,000)	(24,500)			(27,500)
Repurchase of common stock, shares				(3,000,000)
Beneficial conversion feature					281,300			281,300
Net income loss							(4,553,879)	(4,553,879)
Balance at May. 31, 2020			$ 1	$ 130,389	17,992,634	76,000	(18,689,762)	(490,738)
Balance, shares at May. 31, 2020			1	130,388,426
Balance at Feb. 29, 2020		$ 1		$ 110,389	14,796,446	76,000	(15,235,028)	(252,192)
Balance, shares at Feb. 29, 2020		1		110,388,426
Option and warrant expense					3,150,855			3,150,855
Exercise of stock options				$ 20,000				20,000
Exercise of stock options, shares				20,000,000
Exchange of preferred stock		$ (1)	$ 1
Exchange of preferred stock, shares		(1)	1
Capital contribution of accrued salary - related party					45,333			45,333
Net income loss							(3,454,734)	(3,454,734)
Balance at May. 31, 2020			$ 1	$ 130,389	$ 17,992,634	$ 76,000	$ (18,689,762)	$ (490,738)
Balance, shares at May. 31, 2020			1	130,388,426

Nature of Operations, Significa

Nature of Operations, Significant Accounting Policies and Going Concern	9 Months Ended
	May 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN	1. NATURE OF OPERATIONS, SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN Nature of Business Operations Bespoke Extracts, Inc. (the "Company") is a Nevada corporation focused on marketing and selling a proprietary line of premium, quality, all natural CBD products in the forms of tinctures, capsules, drops and edibles for the nutraceutical and veterinary markets, which it introduced in mid-2018. Produced using pure, all natural, zero-THC phytocannabinoid-rich ("PCR") hemp-derived isolate, the Company markets its products as dietary supplements through its retail ecommerce store found at www.bespokeextracts.com. In the future, the Company also intends to sell its products through wholesale channels. Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the nine-month period ended May 31, 2020 may not necessarily be indicative of the results that may be expected for the year ending August 31, 2020. For further information, refer to the Company's financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2019. Certain prior period amounts have been reclassified to conform to current period presentation. Going Concern The accompanying financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit for the nine months ended and as of May 31, 2020. This raises substantial doubt about our ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At May 31, 2020 and August 31, 2019, the Company did not have any cash equivalents. Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, prepaid expenses and other assets, accounts payable, accrued liabilities and convertible note payable approximate their fair values as of May 31, 2020 and August 31, 2019, respectively, because of their short-term natures. Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At May 31, 2020 and August 31, 2019 the Company has recorded an allowance for doubtful accounts of $2,981 and $0, respectively. Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2020 and August 31, 2019, inventory amounted to $1,264 and $3,171, respectively, which consisted of finished goods. During the year ended August 31, 2019 the Company reserved $52,332 for slow moving inventory. No additional reserve was recorded during the nine months ended May 31, 2020. Revenue Recognition Net revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management's evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues. Net revenues exclude sales and other similar taxes collected from customers. Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 14 day return policy on sales. Stock Option Plans Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718 , Compensation-Stock Compensation, Net Income / Loss per Share Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the "if converted" method. The effect of 3,450,000 warrants and 81,200,000 options is anti-dilutive for the three and nine months end May 31, 2020. The effect of 3,330,000 warrants and 1,200,000 options is anti-dilutive for the three and nine months ended May 31, 2019. Change of Control On April 16, 2020, Niquana Noel sold 1 outstanding share of Series C Preferred Stock of the Company to Danil Pollack for $24,000 in a private transaction. The Series C Preferred Stock entitles the holder to 51% of the voting power of the Company's stockholders, and the stock sale thus resulted in a change in control of the Company. Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases The adoption of ASU 2016-02 did not have an impact on our balance sheet, results of operations or balance sheets as we currently do not have any long term corporate office and equipment leases.

Asset Purchase Agreement

Asset Purchase Agreement	9 Months Ended
	May 31, 2020
Offsetting [Abstract]
ASSET PURCHASE AGREEMENT	2. ASSET PURCHASE AGREEMENT On February 21, 2017, the Company purchased all right, title, interest and goodwill in or associated with certain domain names set forth in an asset purchase agreement for a total of $20,185 in cash and 200,000 shares of the Company's common stock valued at $30,000. For the three and nine months ended May 31, 2020 amortization expense amounted to $811 and $2,508, respectively. For the three and nine months ended May 31, 2019 amortization expense amounted to $836 and $2,509, respectively. The domain names are being amortized over a 15 year period. During the nine months ended May 31, 2020, the Company recorded an impairment expense of $289 for expired domain names. On December 24, 2019, the Company repaid a note holder $120,000, and transferred certain URLs valued at $5,282 to the holder (See note 3.)

Convertible Note Payable

Convertible Note Payable	9 Months Ended
	May 31, 2020
Debt Disclosure [Abstract]
CONVERTIBLE NOTE PAYABLE	3. CONVERTIBLE NOTE PAYABLE On November 6, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700 ($0.013 per share). As amended, the debenture had a maturity date of August 1, 2020 and was convertible into shares of common stock of the Company at a conversion price of $0.006, provided that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.001 (subject to adjustment for stock splits, stock dividends and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company recorded beneficial conversion of $36,300 due to the conversion feature. The debenture could not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The Company's obligation to repay the debenture upon maturity was secured by a security interest in the Company's URLs pursuant to a security agreement between the Company and the investor. On December 24, 2019, the Company entered into an agreement (the "Repayment Agreement") with the holder of the amended and restated original issue discount convertible debenture issued by the Company on November 11, 2019, in the original principal amount of $200,000 (the "November 2019 Debenture"). Pursuant to the Repayment Agreement, the Company paid the holder $120,000, and transferred certain URLs valued at $5,282 to the holder, and the November 2019 Debenture was deemed paid in full. The amortization of debt discount of $0 and $35,688, respectively were recorded during the three and nine months ended May 31, 2020. The Company recognized a loss on settlement of debt of $0 and $89,595, respectively during the three and nine months ended May 31, 2020. On December 24, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock valued at $55,000 ($.005 per share). The Company recorded beneficial conversion of $245,000 due to the conversion feature. The debenture may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The debenture had an original maturity date of April 30, 2020 and is convertible into shares of common stock of the Company at a conversion price of $0.001, except that, if the Company fails to repay the debenture upon maturity, the conversion price will be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the debenture will bear interest at the rate of 9% per year. The Company's obligation to repay the debenture upon maturity was initially secured by a security interest in the Company's inventory pursuant to a security agreement between the Company and the investor. For the three and nine months ended May 31, 2020 the Company recorded amortization of debt discount of $242,188 and $500,000 respectively. On April 23, 2020, the Company entered into an amendment to the security agreement, dated December 24, 2019 the Security Agreement Amendment, between the Company and the holder of the Company's original issue discount convertible debenture, dated December 24, 2019. Pursuant to the security agreement amendment, the collateral under the security agreement was amended to be the Company's URLs. The security agreement Amendment was entered into with The Vantage Group Ltd., as the purchaser of the debenture from the original holder. Vantage is owned by Lyle Hauser, an adviser to the Company and formerly a significant stockholder of the Company. On May 28, 2020, the Company entered into an amendment to the original issue discount convertible debenture, dated December 24, 2019, between the Company and The Vantage Group Ltd., the holder of the debenture. Pursuant to the debenture amendment, the maturity date of the debenture was extended to August 31, 2020.

Equity

Equity	9 Months Ended
	May 31, 2020
Equity [Abstract]
EQUITY	4. EQUITY Common Stock and Preferred Stock The Company has authorized capital of 800,000,000 shares of common stock with a par value of $0.001, and 50,000,000 shares of preferred stock with a par value of $0.001. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock. No shares of Series A Preferred Stock are issued and outstanding as of May 31, 2020 and August 31, 2019, respectively. 1 share of preferred stock was designated Series B Preferred Stock. 0 shares of Series B Preferred Stock are issued and outstanding as of May 31, 2020 and August 31, 2019, respectively. The Certificate of Designation of Series B Preferred Stock was withdrawn by the Company on June 30, 2020. 1 share of preferred stock is designated Series C Preferred Stock. 1 share and 0 shares of Series C Preferred Stock are issued and outstanding as of May 31, 2020 and August 31, 2019, respectively. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company's stockholders. The Company may, in its sole discretion, redeem the Series C Preferred Stock at any time for a redemption price equal to the stated value. Upon payment of the redemption price by the Company, the Series C Preferred Stock will revert to the status of authorized but unissued preferred stock. On October 30, 2018, the Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel would serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel's annual salary was $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company's common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant for $2,000 and was issued the 20,000,000 shares on October 31, 2018. The shares received upon the exercise of the warrants were subject to forfeiture over a service period of four years. See "Warrants" below. Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of May 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On October 3, 2019, the Company entered into a letter agreement with Niquana Noel, the Company's then-chief executive officer. Pursuant to the agreement, Ms. Noel exchanged $24,000 in accrued but unpaid compensation owed to her by the Company for one share of newly created Series B Preferred Stock of the Company. Ms. Noel subsequently exchanged this one share of Series B Preferred for 1 one share of newly created Series C Preferred Stock. See Note 5. In connection with the letter agreement, on October 3, 2019, the Company filed a Certificate of Designation of Series B Preferred Stock with the Secretary of State of Nevada. Pursuant to the Certificate of Designation, the Company designated one share of its preferred stock as Series B Preferred Stock. See "Common Stock and Preferred Stock" above. On October 14, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor pursuant to which the Company issued and sold to the investor 20,833,333 shares of common stock for a purchase price of $125,000. In November 2019, 3,000,000 shares of common stock were returned to the Company for cancellation and the Company paid $27,500 in connection with a settlement agreement. On November 6, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700, ($0.013 per share). See Note 3. Effective November 11, 2019, the Company issued 4,500,000 shares of common stock pursuant to a consulting agreement valued at $40,500 ($0.009 per share). On December 24, 2019, the Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock valued at $55,000 ($.005 per share). On March 25, 2020, Company entered into a letter agreement with Niquana Noel, the Company's chief executive officer. Pursuant to the agreement, Ms. Noel exchanged 1 share of Series B Preferred Stock of the Company for one share of newly created Series C Preferred Stock of the Company. In connection with the letter agreement, on March 25, 2020, the Company filed a Certificate of Designation of Series C Preferred Stock with the Secretary of State of Nevada. Pursuant to the Certificate of Designation, the Company designated one share of its preferred stock as Series C Preferred Stock. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company's stockholders. The Company may, in its sole discretion, redeem the Series C Preferred Stock at any time for a redemption price equal to the stated value. The Series C Preferred Stock has a liquidation preference equal to the stated value, does not provide the holder with any dividend rights and is not convertible to common stock. On April 16, 2020, Niquana Noel sold 1 outstanding share of Series C Preferred Stock of the Company to Danil Pollack for $24,000 in a private transaction. The Series C Preferred Stock entitles the holder to 51% of the voting power of the Company's stockholders, and the stock sale thus resulted in a change in control of the Company. Warrants On May 22, 2017, the Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Mr. Yahr received a warrant to purchase up to 20,000,000 shares of the Company's common stock at an exercise price of $0.0001 per share. The warrants were exercised in full on May 31, 2017; however, the 20,000,000 shares of the Company's common stock were not issued to Mr. Yahr until June 10, 2017. The shares received upon the exercise of the warrants were subject to forfeiture over a service period of three years. The fair value of the award was determined to be $10,998,105 which will be recognized as compensation expense over the three year service period. Effective October 30, 2018, Marc Yahr resigned from all positions with the Company including as President and Chief Executive Officer of the Company (except as director, which he resigned as on November 25, 2018). Pursuant to the agreement, Mr. Yahr agreed to return 80% of the warrant shares to the Company if he served as CEO of the Company pursuant to the terms and conditions of the employment agreement for a period of more than 12 months but less than 18 months. Therefore, 16,000,000 shares of common stock were forfeited to the Company, and the Company recognized a gain on the forfeited common shares of ($2,440,768) net of $1,600 paid by the Company during the nine months ended May 31, 2019. As of May 31, 2019, $0 remains to be expensed over the remaining vesting period. On March 2, 2018 the Company entered into a management agreement with Global Corporate Management, LLC. Pursuant to this agreement, the Company agreed to pay $4,000 and to issue 150,000 common stock purchase warrants per month (an aggregate of 3,600,000 warrants) with an exercise price of $0.50, exercisable commencing six months after issuance for a period of 5 years. During the three and nine months ended May 31, 2020 the Company recognized a gain of $0 and $(3,378), respectively due to a remeasurement of this nonemployee award. During the three and nine months ended May 31, 2019 the Company recognized a (gain) / expense of $(179,422) and $(1,452,203), respectively due to a remeasurement of this nonemployee award. On March 2, 2019 the agreement was terminated. On April 16, 2018, the Company entered into a consulting agreement with Dr. David Hellman for marketing and promotion services. The term is 1 year with payment of 50,000 warrants each month to purchase common stock with an exercise price of $0.60. However, if the consultant generates more than $10,000 in monthly sales, the warrants will have an exercise price of $.30, and if the consultant generates more than $20,000 in monthly sales, the warrants may be exchanged in "cashless exercise". Additionally, the Company shall pay 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants each month to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. A total of $256,038 warrant expense in relation to this award was recognized during the year ended August 31, 2018. During the three and nine months ended May 31, 2020 the Company recognized an expense / (gain) of $0 and ($1,905), respectively due to a remeasurement of this nonemployee award. The warrants may be exercised on a cashless basis. During the three and nine months ended May 31, 2019 the Company recognized an expense / (gain) of $12,499 and $(95,119), respectively due to a remeasurement of this nonemployee award. On October 30, 2018, the Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel would serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel's annual salary was $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company's common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant and was issued the 20,000,000 shares on October 31, 2018. The fair value of this award was determined to be $2,598,138 of which $160,040 and $321,868 and was recognized during the three and nine months ended May 31, 2020. The fair value of this award was determined to be $2,598,138 of which $1,733,880 and $2,055,748 was recognized during the three and nine months ended May 31, 2020, respectively. During the three and nine months ended May 31, 2019 $162,272 and $378,784 was recognized, respectively. On April 20, 2020, the Company entered into a letter agreement with Niquana Noel, the Company's then-chief executive officer. Pursuant to the letter agreement, Ms. Noel waived $45,333 of accrued but unpaid compensation owed to her in exchange for the right to retain all 20,000,000 shares of common stock of the Company Ms. Noel had acquired upon exercise of warrants, notwithstanding provisions of the warrant agreement that would have required her to return certain shares to the Company in the event of her resignation. The following table summarizes the warrant activities during the nine months ended May 31, 2020: Number of Weighted- Outstanding at August 31, 2019 3,330,000 $ 0.56 Granted 120,000 0.60 Cancelled or expired - - Exercised - - Outstanding at May 31, 2020 3,450,000 $ 0.56 Exercisable at May 31, 2020 3,450,000 $ 0.56 Intrinsic value at May 31, 2020 $ - The fair value of the warrants was estimated using the Black-Scholes option pricing model and the following range of assumptions: Grant Date For the nine month ended May 31, 2020 Risk-free interest rate at grant date 1.30% - 1.62% Expected stock price volatility 314% - 394% Expected dividend payout - Expected life (in years) 2.50 – 4.50 OPTIONS On July 26, 2017 the Company granted a nonemployee options to purchase 2,200,000 shares of common stock. The options have a three year term. 1,000,000 options were immediately exercisable on the date of issuance with an exercise price of $0.001 and the remaining 1,200,000 options vest over a period of four (4) semiannual installments or every six (6) months until July 26, 2019 at an exercise price of $1.00. As of May 31, 2020 all the options were fully vested. During the three and nine months ended May 31, 2019 the Company recognized an expense / (gain) of $91,939 and $(284,311), respectively. On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack's appointment, the Company entered into an employment agreement with Mr. Pollack. Pursuant to the employment agreement, Mr. Pollack will serve as the Company's chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized an expense of $1,416,975 during the three and nine months ended May 31, 2020. On May 22, 2020 Mr. Pollack exercised 20,000,000 stock options for $20,000. Number of Weighted- Outstanding at August 31, 2019 1,200,000 $ 1.00 Granted 100,000,000 .001 Canceled or expired - - Exercised (20,000,000 ) .001 Outstanding at May 31, 2020 81,200,000 $ .02 Exercisable at May 31, 2020 81,200,000 $ .02 Intrinsic value at May 31, 2020 $ 1,280,000 The fair value of the warrants was estimated using the Black-Scholes option pricing model and the following range of assumptions: Grant Date For the nine month ended May 31, 2020 Risk-free interest rate at grant date .15 % Expected stock price volatility 262 % Expected dividend payout - Expected life (in years) .50

Related Party Transactions

Related Party Transactions	9 Months Ended
	May 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	5. RELATED PARTY TRANSACTIONS On May 22, 2017, the Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement. See Note 4. On October 30, 2018, the Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel would serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. See Note 4. On April 21, 2020, Danil Pollack was appointed president, chief executive officer, and chief financial officer of the Company. In connection with Mr. Pollack's appointment, the Company entered into an employment agreement with Mr. Pollack. Pursuant to the employment agreement, Mr. Pollack will serve as the Company's chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. On May 22, 2020 Mr. Pollack exercised 20,000,000 stock options for $20,000. See Note 4. On March 25, 2020, Company entered into a letter agreement with Niquana Noel, the Company's then-chief executive officer. Pursuant to the agreement, Ms. Noel exchanged 1 share of Series B Preferred Stock of the Company for one share of newly created Series C Preferred Stock of the Company. See Note 4. In connection with the letter agreement, on March 25, 2020, the Company filed a Certificate of Designation of Series C Preferred Stock with the Secretary of State of Nevada. Pursuant to the Certificate of Designation, the Company designated one share of its preferred stock as Series C Preferred Stock. See Note 4.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	May 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	6. COMMITMENTS AND CONTINGENCIES Pursuant to a securities purchase agreement entered into on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of May 31, 2020 and August 31, 2019 the Company was obligated to issue 500,000 shares of common stock valued at $76,000 which is included in the common stock payable in the accompanying balance sheet. The COVID-19 pandemic may negatively affect our operations, including by limiting access to our facilities, customers, management, and professional advisors. These factors, in turn, may negatively impact our operations, financial condition and demand for our products, and our ability to raise capital on acceptable terms, or at all.

Major Customers

Major Customers	9 Months Ended
	May 31, 2020
Risks and Uncertainties [Abstract]
MAJOR CUSTOMERS	7. MAJOR CUSTOMERS There are concentrations of credit risk with respect to accounts receivables due to the amounts owed by one customer at August 31, 2019 whose balance represented approximately 28%, of total accounts receivables. As of May 31, 2020, no customer amounted to over 10% of accounts receivable. During the three and nine months ended May 31, 2020, no individual customer amounted to over 10% of total sales. During the three and nine months ended May 31, 2019, no individual customer amounted to over 10% of total sales. The loss of business from one or a combination of the Company's significant customers, or an unexpected deterioration in their financial condition, could adversely affect the Company's operations.

Subsequent Events

Subsequent Events	9 Months Ended
	May 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	8. SUBSEQUENT EVENTS On June 19, 2020, the Company issued 23,000,000 shares of common stock, for a purchase price of $0.001 per share to Danil Pollack, the Company's chief executive officer, for aggregate gross proceeds of $23,000. The Company issued such shares upon Mr. Pollack's exercise of his right to purchase granted under Mr. Pollack's employment agreement. On June 30, 2020, the Company filed a Certificate of Withdrawal of Certificate of Designation with the Secretary of State of Nevada, pursuant to which the Company withdrew its Series B Preferred Stock.

Nature of Operations, Signifi_2

Nature of Operations, Significant Accounting Policies and Going Concern (Policies)	9 Months Ended
	May 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business Operations	Nature of Business Operations Bespoke Extracts, Inc. (the "Company") is a Nevada corporation focused on marketing and selling a proprietary line of premium, quality, all natural CBD products in the forms of tinctures, capsules, drops and edibles for the nutraceutical and veterinary markets, which it introduced in mid-2018. Produced using pure, all natural, zero-THC phytocannabinoid-rich ("PCR") hemp-derived isolate, the Company markets its products as dietary supplements through its retail ecommerce store found at www.bespokeextracts.com. In the future, the Company also intends to sell its products through wholesale channels.
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments consisting of a normal and recurring nature considered necessary for a fair presentation have been included. Operating results for the nine-month period ended May 31, 2020 may not necessarily be indicative of the results that may be expected for the year ending August 31, 2020. For further information, refer to the Company's financial statements and footnotes thereto included in the Annual Report on Form 10-K for the year ended August 31, 2019. Certain prior period amounts have been reclassified to conform to current period presentation.
Going Concern	Going Concern The accompanying financial statements have been prepared assuming a continuation of the Company as a going concern. The Company had negative cash flows from operations, a working capital deficit and an accumulated deficit for the nine months ended and as of May 31, 2020. This raises substantial doubt about our ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repaying its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. Further, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail or cease our operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These financial statements do not include any adjustments that might arise from this uncertainty.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include all highly liquid investments with original maturities of three months or less at the time of purchase. At May 31, 2020 and August 31, 2019, the Company did not have any cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts of cash, accounts receivable, prepaid expenses and other assets, accounts payable, accrued liabilities and convertible note payable approximate their fair values as of May 31, 2020 and August 31, 2019, respectively, because of their short-term natures.
Accounts Receivable	Accounts Receivable Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense. The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made. At May 31, 2020 and August 31, 2019 the Company has recorded an allowance for doubtful accounts of $2,981 and $0, respectively.
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2020 and August 31, 2019, inventory amounted to $1,264 and $3,171, respectively, which consisted of finished goods. During the year ended August 31, 2019 the Company reserved $52,332 for slow moving inventory. No additional reserve was recorded during the nine months ended May 31, 2020.
Revenue Recognition	Revenue Recognition Net revenue is measured based on the amount of consideration that we expect to receive, reduced by discounts and estimates for credits and returns (calculated based upon previous experience and management's evaluation). Outbound shipping charged to customers is recognized at the time the related merchandise revenues are recognized and are included in net revenues. Inbound and outbound shipping and delivery costs are included in cost of revenues. Net revenues exclude sales and other similar taxes collected from customers. Our products are sold through our online and telephonic channels. Revenue is recognized when control of the merchandise is transferred to the customer, which generally occurs upon shipment. Payment is typically due on the date of shipment. The Company offers a 14 day return policy on sales.
Stock Option Plans	Stock Option Plans Stock options and warrants issued to consultants and other non-employees as compensation for services provided to the Company are accounted for based on the fair value of the services provided or the estimated fair market value of the option or warrant, whichever is more reliably measurable, and in accordance FASB ASC 718 , Compensation-Stock Compensation,
Net Income / Loss per Share	Net Income / Loss per Share Basic income / (loss) per share amounts are computed based on net income / (loss) divided by the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if potentially dilutive securities were exercised or converted to common stock. The dilutive effect of options and warrants and their equivalent is computed by application of the treasury stock method and the effect of convertible securities by the "if converted" method. The effect of 3,450,000 warrants and 81,200,000 options is anti-dilutive for the three and nine months end May 31, 2020. The effect of 3,330,000 warrants and 1,200,000 options is anti-dilutive for the three and nine months ended May 31, 2019.
Change of Control	Change of Control On April 16, 2020, Niquana Noel sold 1 outstanding share of Series C Preferred Stock of the Company to Danil Pollack for $24,000 in a private transaction. The Series C Preferred Stock entitles the holder to 51% of the voting power of the Company's stockholders, and the stock sale thus resulted in a change in control of the Company.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases The adoption of ASU 2016-02 did not have an impact on our balance sheet, results of operations or balance sheets as we currently do not have any long term corporate office and equipment leases.

Equity (Tables)

Equity (Tables)	9 Months Ended
	May 31, 2020
Equity [Abstract]
Schedule of warrant activity and stock options	Number of Weighted- Outstanding at August 31, 2019 3,330,000 $ 0.56 Granted 120,000 0.60 Cancelled or expired - - Exercised - - Outstanding at May 31, 2020 3,450,000 $ 0.56 Exercisable at May 31, 2020 3,450,000 $ 0.56 Intrinsic value at May 31, 2020 $ - Number of Weighted- Outstanding at August 31, 2019 1,200,000 $ 1.00 Granted 100,000,000 .001 Canceled or expired - - Exercised (20,000,000 ) .001 Outstanding at May 31, 2020 81,200,000 $ .02 Exercisable at May 31, 2020 81,200,000 $ .02 Intrinsic value at May 31, 2020 $ 1,280,000
Schedule of fair value of the warrants was estimated using the Black-Scholes option pricing model	Grant Date For the nine month ended May 31, 2020 Risk-free interest rate at grant date 1.30% - 1.62% Expected stock price volatility 314% - 394% Expected dividend payout - Expected life (in years) 2.50 – 4.50 Grant Date For the nine month ended May 31, 2020 Risk-free interest rate at grant date .15 % Expected stock price volatility 262 % Expected dividend payout - Expected life (in years) .50

Nature of Operations, Signifi_3

Nature of Operations, Significant Accounting Policies and Going Concern (Details) - USD ($)	3 Months Ended		9 Months Ended
	May 31, 2020	May 31, 2019	May 31, 2020	May 31, 2019	Apr. 16, 2020	Aug. 31, 2019
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Allowance for doubtful accounts	$ 2,981		$ 2,981			$ 0
Inventory finished goods	$ 1,264		$ 1,264			3,171
Inventory reserves						$ 52,332
Series C Preferred Stock [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Private transaction					$ 24,000
Voting power					51.00%
Options [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Anti-dilutive shares of warrants and options	81,200,000	1,200,000	81,200,000	1,200,000
Warrants [Member]
Nature of Operations, Significant Accounting Policies and Going Concern (Textual)
Anti-dilutive shares of warrants and options	3,450,000	3,330,000	3,450,000	3,330,000

Asset Purchase Agreement (Detai

Asset Purchase Agreement (Details) - USD ($)	Dec. 24, 2019	May 31, 2020	May 31, 2019	May 31, 2020	May 31, 2019	Feb. 21, 2017
Asset Purchase Agreement (Textual)
Total approximate amount include in asset purchase agreement						$ 20,185
Number of common stock						200,000
Common stock value						$ 30,000
Amortization expense		$ 811	$ 836	$ 2,508	$ 2,509
Amortized over period				15 years
Repaid of note holder	$ 120,000
Transferred certain URLs values to holder	$ 5,282

Convertible Note Payable (Detai

Convertible Note Payable (Details) - USD ($)	Dec. 24, 2019	Nov. 06, 2019	May 31, 2020	May 31, 2019	May 31, 2020	May 31, 2019
Convertible Note Payable (Textual)
Securities purchase agreement, description	The Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture in the principal amount of $500,000, for a purchase price of $300,000. The Company also issued to the investor 5,000,000 shares of common stock valued at $55,000 ($.005 per share). The Company recorded beneficial conversion of $245,000 due to the conversion feature. The debenture may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock. The debenture had an original maturity date of April 30, 2020 and is convertible into shares of common stock of the Company at a conversion price of $0.001, except that, if the Company fails to repay the debenture upon maturity, the conversion price will be reduced to $0.0004 (subject to adjustment for stock splits, stock dividends, and similar transactions) and the debenture will bear interest at the rate of 9% per year.	The Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700 ($0.013 per share). As amended, the debenture had a maturity date of August 1, 2020 and was convertible into shares of common stock of the Company at a conversion price of $0.006, provided that, if the Company failed to repay the debenture upon maturity, the conversion price would be reduced to $0.001 (subject to adjustment for stock splits, stock dividends and similar transactions) and the debenture would bear interest at the rate of 9% per year. The Company recorded beneficial conversion of $36,300 due to the conversion feature. The debenture could not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company's outstanding common stock.
Repaid of note holder	$ 120,000
Transferred certain URLs values to holder	$ 5,282
Amortization of debt discount			$ 0		$ 535,687	$ 298,147
Recognized loss on settlement of debt					$ (89,595)
Amortization of debt discount, description					The Company recorded amortization of debt discount of $242,188 and $500,000 respectively.
Repayment Agreement [Member]
Convertible Note Payable (Textual)
Securities purchase agreement, description	The original principal amount of $200,000 (the "November 2019 Debenture"). Pursuant to the Repayment Agreement, the Company paid the holder $120,000, and transferred certain URLs valued at $5,282 to the holder, and the November 2019 Debenture was deemed paid in full.

Equity (Details)

Equity (Details) - USD ($)	9 Months Ended
	May 31, 2020
Options [Member]
Class of Warrant or Right [Line Items]
Number of Warrants/Options, Outstanding Beginning balance	1,200,000
Number of Warrants/Options, Granted	100,000,000
Number of Warrants/Options, Cancelled or expired
Number of Warrants/Options, Exercised	(20,000,000)
Number of Warrants/Options, Outstanding Ending balance	81,200,000
Number of Warrants/Options, Exercisable	81,200,000
Weighted-Average Price Per Share, Outstanding Beginning balance	$ 1
Weighted-Average Price Per Share, Granted	.001
Weighted-Average Price Per Share, Cancelled or expired
Weighted-Average Price Per Share, Exercised	.001
Weighted-Average Price Per Share, Outstanding Ending balance	.02
Weighted-Average Price Per Share, Exercisable	$ .02
Weighted-Average Price Per Share Intrinsic value	$ 1,280,000
Warrants [Member]
Class of Warrant or Right [Line Items]
Number of Warrants/Options, Outstanding Beginning balance	3,330,000
Number of Warrants/Options, Granted	120,000
Number of Warrants/Options, Cancelled or expired
Number of Warrants/Options, Exercised
Number of Warrants/Options, Outstanding Ending balance	3,450,000
Number of Warrants/Options, Exercisable	3,450,000
Weighted-Average Price Per Share, Outstanding Beginning balance	$ 0.56
Weighted-Average Price Per Share, Granted	0.60
Weighted-Average Price Per Share, Cancelled or expired
Weighted-Average Price Per Share, Exercised
Weighted-Average Price Per Share, Outstanding Ending balance	0.56
Weighted-Average Price Per Share, Exercisable	$ 0.56
Weighted-Average Price Per Share Intrinsic value

Equity (Details 1)

Equity (Details 1)	9 Months Ended
	May 31, 2020
Options [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	0.15%
Expected stock price volatility	262.00%
Expected dividend payout
Expected life (in years)	6 months
Warrants [Member]
Class of Warrant or Right [Line Items]
Expected dividend payout
Warrants [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	1.30%
Expected stock price volatility	314.00%
Expected life (in years)	2 years 6 months
Warrants [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Risk-free interest rate at grant date	1.62%
Expected stock price volatility	394.00%
Expected life (in years)	4 years 6 months

Equity (Details Textual)

Equity (Details Textual) - USD ($)

Dec. 24, 2019

Nov. 30, 2019

Nov. 06, 2019

Oct. 14, 2019

Oct. 03, 2019

Oct. 30, 2018

Jun. 06, 2018

Mar. 02, 2018

May 25, 2020

Apr. 21, 2020

Apr. 20, 2020

Apr. 16, 2020

Nov. 11, 2019

Oct. 14, 2019

Oct. 31, 2018

Apr. 16, 2018

Jul. 26, 2017

May 22, 2017

May 31, 2020

May 31, 2019

May 31, 2020

May 31, 2019

Aug. 31, 2019

Equity (Textual)

Common stock, shares authorized

800,000,000

800,000,000

800,000,000

Common stock, par value

$ 0.001

$ 0.001

$ 0.001

Preferred stock, shares authorized

50,000,000

50,000,000

50,000,000

Preferred stock, par value

$ 0.001

$ 0.001

$ 0.001

Preferred stock, shares issued

1

1

0

Preferred stock, shares outstanding

1

1

0

Warrant to purchase of common stock

20,000,000

Proceeds from exercise of warrants

Purchase agreement, description

The Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of May 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000.

Convertible principal amount

$ 500,000

Purchase price

$ 300,000

Common stock for services, value

$ 61,950

$ 40,500

$ 181,950

Series B Preferred Stock [Member]

Equity (Textual)

Preferred stock, par value

$ 1

$ 1

$ 1

Preferred stock, designated shares

1

1

1

Preferred stock, shares issued

Preferred stock, shares outstanding

Preferred stock stated value

$ 24,000

$ 24,000

Letter agreement, description

Pursuant to the agreement, Ms. Noel exchanged $24,000 in accrued but unpaid compensation owed to her by the Company for one share of newly created Series B Preferred Stock of the Company. Ms. Noel subsequently exchanged this one share of Series B Preferred for 1 one share of newly created Series C Preferred Stock.

Series C Preferred Stock [Member]

Equity (Textual)

Preferred stock, designated shares

1

1

1

Preferred stock, shares issued

1

1

1

Preferred stock, shares outstanding

0

0

0

Preferred stock stated value

$ 24,000

$ 24,000

$ 24,000

$ 24,000

Holder voting power, description

Pursuant to the Certificate of Designation, the Company designated one share of its preferred stock as Series C Preferred Stock. The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company’s stockholders. The Company may, in its sole discretion, redeem the Series C Preferred Stock at any time for a redemption price equal to the stated value. The Series C Preferred Stock has a liquidation preference equal to the stated value, does not provide the holder with any dividend rights and is not convertible to common stock.

On April 16, 2020, Niquana Noel sold 1 outstanding share of Series C Preferred Stock of the Company to Danil Pollack for $24,000 in a private transaction. The Series C Preferred Stock entitles the holder to 51% of the voting power of the Company’s stockholders, and the stock sale thus resulted in a change in control of the Company.

The holder to 51% of the total voting power of the Company’s stockholders.

Options Exercised

Shares of common stock forfeited

Sale of shares common stock

Common stock for services, shares

Common stock for services, value

Series A Convertible Preferred Stock [Member]

Equity (Textual)

Preferred stock, par value

$ 0.001

$ 0.001

$ 0.001

Preferred stock, designated shares

1,000

1,000

1,000

Preferred stock, shares issued

Preferred stock, shares outstanding

Options Exercised

Shares of common stock forfeited

Sale of shares common stock

Common stock for services, shares

Common stock for services, value

Ms. Noel shall [Member]

Equity (Textual)

Unpaid compensation

$ 24,000

Investor [Member]

Equity (Textual)

Common stock, par value

$ .005

Aggregate common stock shares issued

20,833,333

Aggregate common stock value

$ 125,000

Common stock issued value

$ 55,000

Common stock shares issued

5,000,000

Warrant [Member]

Equity (Textual)

Issuance of options

120,000

Options Exercised

Convertible debt, description

Pursuant to the agreement, Mr. Yahr agreed to return 80% of the warrant shares to the Company if he served as CEO of the Company pursuant to the terms and conditions of the employment agreement for a period of more than 12 months but less than 18 months. Therefore, 16,000,000 shares of common stock were forfeited to the Company, and the Company recognized a gain on the forfeited common shares of ($2,440,768) net of $1,600 paid by the Company during the nine months ended May 31, 2019. As of May 31, 2019, $0 remains to be expensed over the remaining vesting period.

Common Stock [Member]

Equity (Textual)

Options Exercised

20,000,000

20,000,000

Shares of common stock forfeited

16,000,000

Sale of shares common stock

5,585,714

20,833,333

14,552,381

Common stock, description

3,000,000 shares of common stock were returned to the Company for cancellation and the Company paid $27,500 in connection with a settlement agreement.

Common stock for services, shares

4,500,000

1,000,000

4,500,000

20,000,000

Common stock for services, value

$ 4,500

$ 1,000

$ 4,500

$ 20,000

Non Employee Stock Option [Member]

Equity (Textual)

Issuance of options

2,200,000

Options Exercised

1,000,000

Company recognized expense

$ 91,939

(284,311)

Description of common stock

The Company granted a nonemployee options to purchase 2,200,000 shares of common stock. The options have a three year term. 1,000,000 options were immediately exercisable on the date of issuance with an exercise price of $0.001 and the remaining 1,200,000 options vest over a period of four (4) semiannual installments or every six (6) months until July 26, 2019 at an exercise price of $1.00.

Options exercise price

$ 0.001

Options vested shares

1,200,000

Options vested shares, exercise price

$ 1

President [Member]

Equity (Textual)

Warrant to purchase of common stock

20,000,000

Common stock per share price

$ 0.0001

Fair value of warrants

$ 10,998,105

Terms of warrants

3 years

Compensation expense recognized over service period

3 years

Chief Executive Officer [Member]

Equity (Textual)

Letter agreement, description

Pursuant to the agreement, Ms. Noel exchanged 1 share of Series B Preferred Stock of the Company for one share of newly created Series C Preferred Stock of the Company.

Employment agreement, description

The Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement.

Chief Executive Officer [Member] | Warrant [Member]

Equity (Textual)

Letter agreement, description

Pursuant to the letter agreement, Ms. Noel waived $45,333 of accrued but unpaid compensation owed to her in exchange for the right to retain all 20,000,000 shares of common stock of the Company Ms. Noel had acquired upon exercise of warrants, notwithstanding provisions of the warrant agreement that would have required her to return certain shares to the Company in the event of her resignation.

Shares of common stock forfeited

20,000,000

Employment agreement, description

The Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel would serve as the Company's Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel's annual salary was $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company's common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant and was issued the 20,000,000 shares on October 31, 2018. The fair value of this award was determined to be $2,598,138 of which $160,040 and $321,868 and was recognized during the three and nine months ended May 31, 2020. The fair value of this award was determined to be $2,598,138 of which $1,733,880 and $2,055,748 was recognized during the three and nine months ended May 31, 2020, respectively. During the three and nine months ended May 31, 2019 $162,272 and $378,784 was recognized, respectively.

Chief Executive Officer [Member] | Common Stock [Member]

Equity (Textual)

Warrant to purchase of common stock

20,000,000

20,000,000

Common stock per share price

$ 0.0001

Proceeds from exercise of warrants

$ 2,000

Annual salary

$ 96,000

Danil Pollack [Member] | Options [Member]

Equity (Textual)

Employment agreement, description

The Company entered into an employment agreement with Mr. Pollack. Pursuant to the employment agreement, Mr. Pollack will serve as the Company's chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized an expense of $1,416,975 during the three and nine months ended May 31, 2020. On May 22, 2020 Mr. Pollack exercised 20,000,000 stock options for $20,000.

Global Corporate Management, LLC [Member]

Equity (Textual)

Warrant to purchase of common stock

150,000

Common stock per share price

$ 0.50

Terms of warrants

5 years

Company recognized expense

0

(179,422)

(3,378)

(1,452,203)

Aggregate common stock shares issued

4,000

Global Corporate Management, LLC [Member] | Warrant [Member]

Equity (Textual)

Warrant to purchase of common stock

3,600,000

Employment Agreement [Member]

Equity (Textual)

Employment agreement, description

The Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company’s Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement.

Pursuant to the employment agreement, Mr. Pollack will serve as the Company’s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. On May 22, 2020 Mr. Pollack exercised 20,000,000 stock options for $20,000.

Purchase agreement, description

Niquana Noel pursuant to which Ms. Noel would serve as the Company’s Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement. Pursuant to the terms of the employment agreement, Ms. Noel’s annual salary was $96,000 and she received a warrant to purchase up to 20,000,000 shares of the Company’s common stock at an exercise price of $0.0001 per share. Ms. Noel exercised the warrant for $2,000 and was issued the 20,000,000 shares on October 31, 2018.

Consulting Agreement [Member] | Dr. David Hellman [Member]

Equity (Textual)

Warrant to purchase of common stock

50,000

Common stock per share price

$ 0.60

Terms of warrants

1 year

Company recognized expense

$ 0

$ 12,499

(1,905)

$ (95,119)

Consulting agreement, description

If the Consultant generates more than $10,000 in monthly sales, the Warrants will have an exercise price of $.30, and if the Consultant generates more than $20,000 in monthly sales, the Warrants may be exchanged in “cashless exercise”. Additionally, the Company shall pay 10% of retail sales and 5% of wholesale sales. On July 11, 2018 the Company terminated the agreement. On August 1, 2018 the Company entered into a new consulting agreement with Dr. Hellman. The term is 1 year with payment of 60,000 warrants each month to purchase common stock with an exercise price of $0.60. The warrants may be exercised on a cashless basis. A total of $256,038 warrant expense in relation to this award was recognized during the year ended August 31, 2018.

Securities Purchase Agreement [Member]

Equity (Textual)

Warrant to purchase of common stock

0.10

Dividend

$ 50,000

Purchase agreement, description

The Company entered into and closed a securities purchase agreement with an accredited investor, pursuant to which, the Company issued and sold to the investor an original issue discount convertible debenture (which was amended and restated on November 11, 2019) in the principal amount of $200,000, for a purchase price of $100,000, resulting in an original issue discount of $100,000. The Company also issued to the investor 4,900,000 shares of common stock valued at $63,700, ($0.013 per share).

Common stock issued value

$ 76,000

Common stock shares issued

500,000

500,000

Securities Purchase Agreement [Member] | Investor [Member]

Equity (Textual)

Description of common stock

The Company issued and sold to the investor 20,833,333 shares of common stock for a purchase price of $125,000.

Related Party Transactions (Det

Related Party Transactions (Details)	Oct. 30, 2018	May 25, 2020	Apr. 21, 2020	May 22, 2017
Chief Executive Officer [Member]
Related Party Transactions (Textual)
Employment agreement, description				The Company entered into an employment agreement with Marc Yahr to serve as President and Chief Executive Officer of the Company for a term of three years, unless earlier terminated pursuant to the terms of the employment agreement.
Letter agreement, description		Pursuant to the agreement, Ms. Noel exchanged 1 share of Series B Preferred Stock of the Company for one share of newly created Series C Preferred Stock of the Company.
Employment Agreement [Member]
Related Party Transactions (Textual)
Employment agreement, description	The Company entered into an employment agreement with Niquana Noel pursuant to which Ms. Noel will serve as the Company’s Chief Executive Officer and president for a term of four years, unless earlier terminated pursuant to the terms of the employment agreement.		Pursuant to the employment agreement, Mr. Pollack will serve as the Company’s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. On May 22, 2020 Mr. Pollack exercised 20,000,000 stock options for $20,000.

Commitments and Contingencies (

Commitments and Contingencies (Details) - Securities Purchase Agreement [Member] - USD ($)	Jun. 06, 2018	May 31, 2020	Aug. 31, 2019
Commitments and Contingencies (Textual)
Value of common stock		$ 76,000	$ 76,000
Exercise price	$ 0.10
Dividend	$ 50,000
Issuance of common stock		500,000	500,000

Major Customers (Details)

Major Customers (Details) - Customers	3 Months Ended		9 Months Ended		12 Months Ended
	May 31, 2020	May 31, 2019	May 31, 2020	May 31, 2019	Aug. 31, 2019
Sales [Member]
Major Customers (Textual)
Concentrations of credit risk	10.00%	10.00%	10.00%	10.00%
Accounts Receivable [Member]
Major Customers (Textual)
Concentrations of credit risk			10.00%		28.00%
Number of customers					1

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended
	Jun. 19, 2020	May 31, 2019	May 31, 2020	May 31, 2019
Subsequent Events (Textual)
Gross proceeds		$ 61,950	$ 40,500	$ 181,950
Subsequent Event [Member]
Subsequent Events (Textual)
Issuance of common stock	23,000,000
Gross proceeds	$ 23,000
Purchase price	$ 0.001